New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Is BPC157 Legal? WADA, FDA Status, and What You Need to Know Convergence of machine learning and genomics for precision oncology Nature Reviews Cancer